Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.3 (
ATPase
)
65,361
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The influence of the physiological ligands and modifiers on the plasma membrane Na+, K+ -
ATPase
from calf brain inactivation by sodium fluoride (NaF) is studied. ATP-hydrolyzing activity of the enzyme was found to be more stable as to NaF inhibition than its K+ -pNPPase activity. The activatory ions of Na+, K+ -
ATPase
have different effects on the process of the enzyme inhibition by NaF. K+ intensifies inhibition, but Na+ does not affect it. An increase of [Mg2+free] in the incubation medium (from 0.5 to 3.0 mM) rises the sensitivity of Na+, K+ -
ATPase
to NaF inhibition. But an increase of [ATP] from 0.3 to 1.5 mM has no effect on this process. Ca and Mg ions modify Na+, K+ -
ATPase
inhibition by fluoride differently. Ca2+free levels this process, and Mg2+free on the contrary increases it. In the presence of Ca ions and in the neutral-alkaline medium (pH 7.0-8.5) the recovery of activity of the transport
ATPase
inhibited by-NaF takes place.
Sodium citrate
also protects both ATP-hydrolizing and K-pNPPase activity of the Na+, K+ -
ATPase
from NaF inhibition. Under the modifing membranous effects (the treatment of plasma membranes by Ds-Na and digitonin) the partial loss of Na+, K+ -
ATPase
sensitivity to NaF inhibition is observed. It is concluded that Na+, K+ -
ATPase
inactivation by NaF depends on the influence of the physiological ligands and modifiers as well as on the integrity of membrane structure.
...
PMID:[Inactivation of Na+, K+ -ATPase from cattle brain by sodium fluoride]. 1590 16